After Hours Report

The stock market started the week on a higher note, with the S&P 500 (+0.7%), Nasdaq Composite (+0.8%), and DJIA (+0.3%) all advancing as renewed buying interest in semiconductor stocks, AI infrastructure companies, and other growth-oriented names provided support. The gains helped the S&P 500 and Nasdaq recover some of last week's losses, while the DJIA built on its gain from last week. The S&P 500 briefly eclipsed its 50-day moving average (7,698) during the session but failed to close above that level.

Today's rebound followed a difficult stretch for the AI trade, particularly Thursday's sharp selloff, when concerns about the financing requirements of expanding AI infrastructure weighed heavily on technology stocks. Reports that Meta Platforms (META 630.56, -12.06, -1.88%) is seeking to raise $95 billion in equity for its AI expansion, alongside SpaceX's (SPCX 146.90, -0.59, -0.40%) $40 billion debt financing for GPU purchases, brought renewed attention to the enormous investments being made in the industry. Anthropic also filed its S-1 registration statement ahead of a potential IPO, reporting rapid revenue growth that reinforced expectations for expanding demand for AI services, even as questions about infrastructure costs and returns on investment persist.

The information technology sector (+1.5%) led the advance, supported by a strong rebound in semiconductor stocks that lifted the PHLX Semiconductor Index 2.8%. NVIDIA (NVDA 216.02, +5.06, +2.40%) was among the notable beneficiaries of renewed interest in the AI trade, while the industrials sector (+1.4%) also received support from AI infrastructure-related names. The consumer discretionary sector (+1.1%) was another standout, helped by a sizable gain in Tesla (TSLA 391.62, +19.40, +5.21%) following an upgrade to Overweight from Equalweight at Barclays.

Lower oil prices also provided a tailwind for a variety of consumer discretionary stocks, with WTI crude futures settling $1.41 lower (-1.4%) at $101.76 per barrel. Late in the session, The Wall Street Journal reported that DoorDash (DASH 168.44, -10.94, -6.10%) is in discussions to acquire Instacart (CART 60.88, +4.44, +7.87%).

Mega-cap growth stocks made an outsized contribution to the broader market's advance, with the Vanguard Mega Cap Growth ETF (+0.9%) outperforming the S&P 500 Equal Weighted Index (+0.3%). Apple (AAPL 343.91, -3.82, -1.10%) was a notable exception to the technology strength, The gains across smaller and mid-sized companies reflected some participation beyond the largest stocks, although leadership remained concentrated in growth-oriented areas.

The communication services sector (-1.4%) was the session's clear laggard, weighed down by weakness in mega-cap constituents Meta Platforms (META 630.56, -12.06, -1.88%) and Alphabet (GOOG 314.19, -3.09, -0.97%), alongside several company-specific declines. Verizon (VZ 43.11, -1.55, -3.47%) fell despite beating earnings expectations and raising its FY26 outlook, as a revenue shortfall and concerns about future wireless competition overshadowed the positive developments. Netflix (NFLX 63.90, -1.95, -2.96%) also struggled following a Bloomberg report about declining time spent on the platform.

Defensive areas generally lagged, with the health care and utilities sectors finishing flat and the consumer staples sector (-0.1%) slipping slightly. Dollar General (DG 128.42, -4.27, -3.22%) was among the notable laggards after the FTC and state partners filed a lawsuit alleging that the retailer charged consumers more than advertised for numerous products.

The energy sector (+0.5%) finished higher despite the decline in crude oil prices, with refiner names outperforming. EQT Corp. (EQT 54.85, -0.78, -1.40%) fell following its agreement to acquire Range Resources (RRC 53.58, +8.06, +17.71%) in an all-stock transaction, while Range Resources rallied.

The early-week advance comes ahead of a considerably busier stretch for both corporate earnings and economic data, beginning tomorrow. According to FactSet, 179 S&P 500 companies are scheduled to report earnings this week, including major technology companies whose results will be closely watched for indications of AI spending trends and profitability.

On the policy front, Wednesday's FOMC decision remains another important event, with markets widely expecting the Fed to leave interest rates unchanged.

U.S. Treasuries started a busy week, which will feature a midweek release of the October FOMC Statement, on a mixed note, with losses in shorter tenors and modest gains on the long end. The early afternoon brought some light pressure on the front end after the U.S. Treasury kicked off this week's note auction slate with a weak 2-year note sale while the long end was essentially unmoved by the result. The 2-year note yield settled up three basis points to 4.71%, and the 10-year note yield finished unchanged at 4.99%.

There was no economic data of note today.

• Nasdaq Composite: +12.6% YTD
• Russell 2000: +12.3% YTD
• S&P 500: +12.1% YTD
• S&P Mid Cap 400: +10.2% YTD
• DJIA: +8.9% YTD

Overseas:

• Europe: DAX +1.0%, FTSE +0.7%, CAC +0.8%
• Asia: Nikkei -0.8%, Hang Seng +0.5%, Shanghai +0.2%

Commodities:

• Crude Oil -1.41 @ 101.76
• Nat Gas -0.04 @ 2.60
• Gold +30.50 @ 4037.90
• Silver +0.41 @ 54.35
• Copper +0.03 @ 6.54

After-Hours Spotlight:

• Agilysys (AGYS) beats by $0.12, beats on revs; guides FY27 revs in-line with consensus
• Alexandria RE (ARE) beats by $0.01, beats on revs; guides FY26 FFO in-line
• Amkor (AMKR) misses by $0.02, misses on revs; guides Q4 EPS below consensus, revs below consensus
• Broadcom (AVGO) backed $63 bln AI compute financing structure formed for Anthropic with BAC, BX, Citi and Morgan Stanley
• Cadence Design (CDNS) beats by $0.06, beats on revs; raises FY26 EPS above consensus, revs above consensus
• Greenbrier (GBX) reports Q4 (Aug) results, misses on revs; guides FY27 EPS in-line, revs above consensus
• Intel (INTC) to acquire Classiq in quantum software deal
• JetBlue Airways (JBLU) misses by $0.06, reports revs in-line
• Noble Corporation (NE) misses by $0.80, beats on revs; guides FY26 revs in-line with consensus
• Nucor (NUE) misses by $0.04, beats on revs
• Rambus (RMBS) reports third quarter 2026 financial results
• Whirlpool (WHR) misses by $0.94, misses on revs; cuts FY26 EPS below consensus, revs below consensus

For a full rundown of today's market and after hours developments, see Live In Play

• Earnings/Guidance (Full Earnings Calendar):
  • Alliance Resource Partners (ARLP) reports third quarter 2026 financial and operating results and updates guidance
  • Bank of Hawaii (BOH) misses by $0.02
  • Easterly Government Properties (DEA) reports EPS in-line, beats on revs; guides FY26 Core FFO in-line with consensus; guides FY27 Core FFO in-line with consensus
  • Lakeland Financial (LKFN) beats by $0.05, misses on revs
  • Verizon (VZ) beats by $0.04, misses on revs; raises FY26 EPS guidance above consensus
• General News
  • U.S. prepared for major strikes against Iran, if ordered by President Trump. CNN
  • Lula da Silva wins Brazil's presidential election in an upset. Bloomberg
  • Democrats are expected to win 229 House seats, and Republicans are expected to win 206 following the midterm elections. CBS News
  • Officials from Saudi Arabia, Pakistan, and Turkey will travel to Iran to attempt to restart peace talks. Bloomberg
  • Bon Secours Mercy Health in discussions to purchase stake in Surgery Partners. FT
  • The EU is planning to lower imports of chemicals, furniture, and machinery from China. Bloomberg.
  • Voya activist TCIM says SEC effort to block no-confidence vote failed
  • A dispute at a Boeing (BA) supplier has halted 777 freighter production for two months. Reuters
  • Amarin (AMRN): Leeds-sponsored Phase 3 EMT2 misses PFS primary endpoint, shows OS benefit for VAZKEPA/VASCEPA in CRCLM
  • Apollo Global Management to purchase 10% stake in Mubadala Capital, according to CNBC (INSID)
  • Apple (AAPL) aiming to introduce a MacBook Pro with a touchscreen. Bloomberg
  • ArriVent (AVBP) posts initial Phase 1 ARR-217 data in GI cancers; 44.8% ORR at 6 mg/kg in late-line CRC
  • ArriVent (AVBP) to present initial Phase 1 ARR-217 GI cancer data at ESMO late-breaking session
  • AutoZone (AZO) CFO Jamere Jackson to depart Nov. 25 for FedEx CFO role
  • Bayer's asundexian becomes first FXIa inhibitor (BAYRY) approved worldwide with China authorization
  • Bayer's Nubeqa reduces risk of metastasis or death by 58% in Phase III prostate cancer trial (BAYRY)
  • BioNTech (BNTX) and Bristol Myers (BMY) report 36.7% response rate for pumitamig combination in Phase II second-line NSCLC trial
  • BioNTech (BNTX) and DualityBio Phase III breast cancer trial meets PFS endpoint, but companies cite limited potential benefit
  • Braskem (BAK)'s creditors and shareholders are moving closer to an agreement. Bloomberg
  • Braskem (BAK), creditors remain at odds on restructuring terms ahead of Oct. 30 deadline
  • Celcuity presents updated Phase 3 VIKTORIA-1 subgroup data for gedatolisib in HR+/HER2- breast cancer (PFE)
  • Climb Bio (CLYM) posts Phase 1 CLYM116/MIL116 data showing durable APRIL suppression, ~70% Gd-IgA1 reduction
  • Climb Bio (CLYM) presents initial Phase 2 budoprutug pMN data showing early immunologic activity
  • Cognizant (CTSH) selected by EBRD for five-year AI-led technology services framework
  • Corcept (CORT) reports positive Phase 2 BELLA data for Lifyorli triplet in platinum-resistant ovarian cancer
  • Cumberland Pharma (CPIX) reports Phase 2a ASSIST-SSc top-line results for ifetroban
  • Delek Logistics Partners (DKL) raises quarterly dividend to $1.14 from $1.135
  • Eikon presents updated EIK1001 NSCLC data at ESMO; Phase 2/3 TeLuRide-008 interim dose-selection analysis eyed in 2H27 (MRK)
  • Elbit Systems (ESLT) wins about $200 mln Asia-Pacific airborne ISTAR, training contracts
  • Fate Therapeutics (FATE) presents updated FT819 Phase 1 lupus nephritis data; Month 6 renal response 100% in selected cohort
  • Fluor (FLR) awarded a $2.41 bln modification to previously awarded Navy contract for Naval Nuclear Propulsion work
  • Genmab (GMAB) presents updated Phase 2 petosemtamab mCRC data with 75% ORR in first line
  • Genmab updates Phase 2 petosemtamab plus pembrolizumab data in 1L head and neck cancer; median OS 28.2 months (MRK)
  • Genmab, Incyte (INCY) enter mCRC trial collaboration for petosemtamab and INCB161734
  • GSK (GSK) plc reports 62% response rate for Mo-Rez in Phase I platinum-resistant ovarian cancer trial
  • GSK (GSK) plc reports 76% complete response rate with Jemperli alone in Phase II rectal cancer trial
  • GXO Logistics (GXO) and Agility Robotics expand partnership to accelerate deployment of humanoids in U.S. operations
  • Howard Hughes Holdings to join S&P SmallCap 600, replacing Arcosa after CRH (CRH) deal close
  • HUTCHMED highlights Phase III SANOVO data for ORPATHYS plus AstraZeneca (AZN)'s TAGRISSO in first-line EGFR-mutated NSCLC
  • Hyperliquid Strategies (PURR) boosts stock buyback authorization to $100 mln, extends program through Oct. 2027
  • Iambic (IAM) posts updated Phase 1/1b IAM1363 data showing durable responses in HER2-driven cancers
  • Immuneering (IMRX) Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026
  • Immunome (IMNM) presents additional varegacestat Phase 3 desmoid tumor data at ESMO
  • Incyte (INCY), Genmab (GMAB) enter mCRC trial collaboration for INCB161734 and petosemtamab
  • J&J (JNJ) reports 75% confirmed tumor response rate for JNJ-6143 in Phase 1 advanced prostate cancer study
  • JetBlue (JBLU) creditors have hired advisors amid a decline in bonds. WSJ
  • Lockheed Martin (LMT) awarded a $114.6 mln Navy contract
  • MacroGenics (MGNX) announces positive interim phase 2 LINNET results for Lorigerlimab in advanced clear cell gynecologic cancer
  • Middlesex Water (MSEX) increases quarterly dividend by 5.56% to $0.38/share from $0.36/share
  • Moderna and Merck (MRK) Phase III melanoma trial shows 42% reduction in risk of recurrence or death with intismeran combination
  • Nanobiotix (JNJ) reports 41.7% response rate for JNJ-1900 in Phase I anti-PD-1-resistant melanoma study
  • Netflix (NFLX) users are spending less time on the platform. Bloomberg
  • NovaBridge (NBP) says updated Phase 1b givastomig data support registrational development in gastroesophageal adenocarcinoma
  • Nu CTO Eric Young to resign; CEO David Vélez to oversee Global Platforms on interim basis – 6-K filing (NU)
  • Oruka (ORKA) reports positive Week 16 Phase 2b psoriasis data for ORKA-001; high-dose PASI 100 at 61%
  • Parabilis (PBLS) presents updated zolucatetide desmoid tumor data; Phase 3 PEDESTAL planned for 1H27
  • Pfizer (PFE) presents Phase 2 infant data for 25-valent pneumococcal vaccine candidate
  • Regeneron Pharma (REGN) reports 37% reduction in risk of death with Libtayo in longer-term Phase III CSCC data
  • Roche's divarasib reduces risk of death by 44% versus existing KRAS G12C inhibitors in Phase III lung cancer trial (RHHBY)
  • SharkNinja (SN) unveiled a limited-edition color of the Shark CryoGlow LED Face Mask, in collaboration with SharkNinja global brand ambassador Kevin Hart
  • Six Flags (SIX) will add seat belts to some of its rides amid safety concerns. Washington Post
  • Softbank aiming to (SFTBY) invest $50 billion in Malaysia. Bloomberg
  • Solid Biosciences (SLDB) gets EU orphan designation for SGT-212; initial FALCON data due Q1 2027
  • Summit (AZN) partner Akeso says ivonescimab plus chemo beats durvalumab combo on OS in Phase 3 biliary tract cancer study
  • Summit Therapeutics (SMMT) partners with Lunit on AI pathology research for ivonescimab programs
  • The Anthropic model accessed voter information in Georgia (PANW, CRWD, FTNT, ZS, NET, HACK). Axios (PANW)
  • Travere (TVTX) presents FILSPARI biomarker data from Phase 3 PROTECT in IgA nephropathy
  • Volkswagen selects NXP (NXPI) as strategic chip partner for future zonal vehicle architecture
  • Xencor (MRK) selects 400 mcg/kg RP3D for XmAb819 after updated Phase 1 ccRCC data
  • Zymeworks presents Phase 1 ZW191 ovarian cancer data showing 64.5% cORR at 6.4 mg/kg (JNJ)

• Upgrades:
  • Booz Allen (BAH) upgraded to Buy from Hold at TD Cowen, tgt $95
  • CACI (CACI) upgraded to Buy from Hold at Jefferies, tgt $725
  • ConnectOne Bancorp (CNOB) upgraded to Outperform from Market Perform at Raymond James, tgt $37
  • Dr. Reddy's Laboratories (RDY) upgraded to Hold from Underperform at Jefferies, tgt $13.90
  • Dr. Reddy's Laboratories (RDY) upgraded to Neutral from Underweight at JPMorgan
  • Enterprise Financial (EFSC) upgraded to Overweight from Neutral at Piper Sandler, tgt $64
  • Inspired Entertainment (INSE) upgraded to Outperform from Neutral at Macquarie, tgt $7
  • Kaiser Aluminum (KALU) upgraded to Neutral from Underweight at JPMorgan, tgt $140
  • LKQ Corp. (LKQ) upgraded to Overweight from Equal Weight at Barclays, tgt $25
  • Lockheed Martin (LMT) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $835
  • NorthWestern Energy (NWE) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $90
  • Precision Drilling (PDS) upgraded to Outperform from Sector Perform at National Bank Financial
  • Roper Technologies (ROP) upgraded to Neutral from Underweight at JPMorgan, tgt $490
  • Ross Stores (ROST) upgraded to Buy from Neutral at UBS, tgt $315
  • Safehold (SAFE) upgraded to Equal Weight from Underweight at Morgan Stanley, tgt $12
  • Sono-Tek (SOTK) upgraded to Outperform from Market Perform at Northland, tgt $7
  • Tesla (TSLA) upgraded to Overweight from Equal Weight at Barclays, tgt $450
  • TriCo Bancshares (TCBK) upgraded to Overweight from Neutral at Piper Sandler, tgt $58.50
• Downgrades:
  • Advance Auto Parts (AAP) downgraded to Sell from Neutral at Rothschild & Co Redburn, tgt $32
  • Block (XYZ) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $80
  • Boise Cascade (BCC) downgraded to Hold from Buy at Loop Capital, tgt $85
  • Builders FirstSource (BLDR) downgraded to Hold from Buy at Loop Capital, tgt $62
  • Carpenter Technology (CRS) downgraded to Sector Weight from Overweight at KeyBanc
  • Equifax (EFX) downgraded to Sector Perform from Outperform at RBC Capital, tgt $189
  • EyePoint (EYPT) downgraded to Hold from Buy at Jones Trading
  • FICO (FICO) downgraded to Equal Weight from Overweight at Wells Fargo, tgt $735
  • Floor & Decor (FND) downgraded to Hold from Buy at Stifel, tgt $52
  • LKQ Corp. (LKQ) downgraded to Neutral from Buy at Roth Capital, tgt $18
  • Perspective Therapeutics (CATX) downgraded to Sector Perform from Outperform at RBC Capital, tgt $4
  • Ryman Hospitality (RHP) downgraded to In Line from Outperform at Evercore ISI, tgt $140
  • Sea Limited (SE) downgraded to Neutral from Buy at New Street Research, tgt $70
  • Spotify (SPOT) downgraded to Accumulate from Buy at Phillip Securities, tgt $650
  • Telefonica (TEF) downgraded to Underweight from Neutral at JPMorgan
  • USCB Financial (USCB) downgraded to Outperform from Strong Buy at Raymond James, tgt $23
• Others:
  • Accelevation (ACCV) initiated at Outperform at Baird, tgt $16
  • Accelevation (ACCV) initiated at Overweight at Barclays, tgt $20
  • Accelevation (ACCV) initiated at Buy at BofA Securities, tgt $20
  • Accelevation (ACCV) initiated at Buy at Goldman Sachs, tgt $22
  • Accelevation (ACCV) initiated at Overweight at JPMorgan, tgt $20
  • Accelevation (ACCV) initiated at Equal Weight at Morgan Stanley, tgt $18
  • Accelevation (ACCV) initiated at Outperform at William Blair
  • Accelevation (ACCV) initiated at Outperform at Wolfe Research
  • AutoZone (AZO) resumed at Buy at BofA Securities, tgt $3,800
  • Blackstone Secured Lending Fund (BXSL) initiated at Market Perform at Citizens
  • Centrus Energy (LEU) initiated at Hold at TD Cowen, tgt $120
  • Coherent (COHR) initiated at Buy at StoneX, tgt $425
  • Dare Bioscience (DARE) initiated at Buy at Ladenburg Thalmann, tgt $2
  • Electra Therapeutics (ETRA) initiated at Buy at H.C. Wainwright, tgt $30
  • FirstEnergy (FE) initiated at Outperform at BMO Capital, tgt $50
  • Life Time Group (LTH) initiated at Overweight at Barclays, tgt $51
  • Lumentum (LITE) initiated at Buy at StoneX, tgt $1,200
  • NetApp (NTAP) initiated at Neutral at Guggenheim
  • Nutanix (NTNX) initiated at Buy at Guggenheim, tgt $100
  • Nutex Health (NUTX) initiated at Buy at Ladenburg Thalmann, tgt $336
  • Oaktree Specialty Lending (OCSL) initiated at Market Perform at Citizens
  • Oklo (OKLO) initiated at Hold at TD Cowen, tgt $26
  • O'Reilly Automotive (ORLY) resumed at Buy at BofA Securities, tgt $106
  • Powerlaw (PWRL) initiated at Buy at Stifel
  • Skydance (SKYD) resumed at Buy at Citi, tgt $10
  • Telesat (TSAT) initiated at Outperformer at CIBC
  • Tonix Pharmaceuticals (TNXP) initiated at Buy at Canaccord, tgt $18

• Econ Data (Tuesday):
  • 8:30 ET: September Durable Orders (Briefing.com consensus 1.0%; prior 0.0%) and Durable Orders -ex transport (Briefing.com consensus 0.6%; prior 0.3%) at 8:30 ET
  • 9:00 ET: August FHFA Housing Price Index (Briefing.com consensus 0.2%; prior 0.3%) and August S&P Case-Shiller Home Price Index (Briefing.com consensus 2.8%; prior 2.5%)
  • 10:00 ET: October Consumer Confidence (Briefing.com consensus 80.5; prior 81.9) and September New Home Sales (Briefing.com consensus 655,000; prior 684,000)

• Earnings:
  • Monday (October 26)
    • Pre-Market: BOH, DEA, LKFN, VZ
    • After-Hours: AGYS, AMKR, ARE, BRO, BRX, CDNS, CINF, CTOS, DORM, GBX, HIG, KFRC, NE, NUE, PECO, PFG, PSA, PSMT, SSD, SUI, WELL, WHR
  • Tuesday (October 27)
    • Pre-Market: AB, ABG, AIT, AMT, ARCC, AWI, BA, CBU, CMS, CNC, CNP, CVLT, ECL, EEFT, FCX, GLW, GLXY, HCA, HLT, HRI, HUBB, IQV, ITRI, ITW, IVZ, JBLU, JCI, KO, LECO, MRP, NVS, PCAR, PII, PNR, PYPL, RCL, RGEN, SFD, SHW, SMPL, SOFI, SPGI, SXC, TNL, TRU, UPS, WSO, XYL
    • After-Hours: ACGL, APAM, BANC, BBAI, BKR, BXP, CAKE, CHE, CR, CSGP, CZR, ENPH, EQT, ESS, EXE, EXLS, EXR, FE, FFBC, FFIV, HIW, HOOD, ICLR, INTA, LOGI, LPLA, LSTR, MANH, MCRI, MIR, NBHC, NBR, NOV, NTB, NXPI, OI, OKE, PPG, RBBN, RNR, RNST, RRC, RUSHA, ST, STAG, STX, TER, TRMK, UCTT, UHS, UMBF, V, VTR, WERN, WM, WPC, ZWS
  • Wednesday (October 28)
    • Pre-Market: ADP, AEP, AER, AON, APH, AVTR, BIIB, BLCO, BLKB, BSX, CHEF, CHRW, CLH, CSTM, DAN, DINO, DMC, EAT, ETSY, EVR, EXTR, FELE, FLEX, FTV, GEHC, GEV, GNRC, GPI, GRMN, GSK, HAYW, HOPE, IEX, IP, JLL, JMKE, KEX, LFUS, LH, LII, MAS, MGPI, NI, ODFL, OGE, OSW, OTIS, PAG, PB, PSN, PSX, PUMP, RDWR, SCL, SITE, SKHY, STNG, SW, TEL, TEX, UBS, ULCC, VFC, VRT, WING
    • After-Hours: AEM, AIN, ALGN, ALKT, AM, AMRZ, AR, ARXS, AWK, AXS, BHE, BOOT, CCS, CHDN, CLB, CMG, CNMD, COHU, CP, CSL, CVNA, CYH, DAR, EBAY, EFOR, EG, EHC, EIG, EPAC, EPR, EQIX, F, FCPT, FDX, FLS, FORM, FTNT, GEN, GKOS, GOOG, GRBK, HAPN, HLI, HONA, INVH, KLAC, MAA, MGM, MSFT, MTH, MUSA, MYRG, NEO, NOW, NXT, OLED, ORLY, PBI, PFS, PI, PLXS, PPC, QTWO, RJF, RSI, SFM, SIMO, STRL, TDOC, TENB, THG, TMUS, TYL, VICI, VKTX, WEX
  • Thursday (October 29)
    • Pre-Market: AGCO, ALGM, ALNY, AMP, AOS, APG, ARES, ATI, AVY, AXTA, BAND, BAX, BC, BDC, BG, BLDR, BMY, BUD, BWA, CARR, CAT, CFR, CNX, CRH, CROX, CSW, CTSH, CWT, DFIN, DHI, DRS, DTM, EME, ENTG, EPD, ESTA, FCN, FOR, FSS, FTAI, FTI, FTRE, FVRR, GATX, GTX, GVA, H, HGV, HII, HOG, HSY, HWM, ICE, IDA, IDCC, INCY, INSM, KBR, KIM, KYMR, LAUR, LGND, LHX, LIN, LKQ, LLY, LNG, LTH, MA, MBLY, MD, MNRO, MO, MPT, MRK, NCLH, NMRK, NSP, NVCR, OMCL, OSK, PATK, PBF, PGY, POR, PRLB, PWP, PWR, QSR, RES, SAH, SAIA, SIRI, SLGN, STGW, STM, TECK, THC, TNET, TPG, TRN, TROW, TRS, TT, TW, TXT, UPBD, VMC, WCC, WEC, WNC, WST, WTW, XEL, XPO, XRX
    • After-Hours: AJG, ALHC, AMZN, ATEC, ATR, AX, BBIO, BFAM, CACC, CDNA, CNO, COIN, COLM, COUR, CUBE, CUZ, DLR, DVA, DXC, EIX, EMN, EXEL, EXPO, FHI, FMC, FND, FSLR, GDDY, GILD, GLPI, HR, HTGC, ILMN, INGM, INTC, IR, KWR, LNT, MDLZ, MEOH, MHK, MIAX, MMSI, MPWR, MSTR, MTX, MTZ, OLN, OSIS, PEB, PFSI, PINS, PTCT, RBLX, RDDT, REAL, RIVN, RKT, RMD, RSG, RYAN, SBUX, SKYW, SNDK, SNDR, SPSC, SPXC, SUPN, SYK, TWLO, VLTO, WKC, WY
  • Friday (October 30)
    • Pre-market: ABBV, AN, AZN, BP, BTSG, CBOE, CCJ, CHD, CL, CNI, CPRI, CVX, D, EXC, FRT, GD, GTES, KVUE, LEA, LYB, MGA, MOG.A, NVT, NWL, OIS, OMF, PAYP, PIPR, RBC, REGN, SNY, SXT, TILE, VRRM, WT, XOM
    • Afternoon: None